| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Acute heart failure as an adverse event of tumor necrosis factor inhibitor therapy in inflammatory bowel disease: A review of the literature
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Thais Gagno Grillo, Caroline Ferreira da Silva Mazeto Pupo Silveira, Ana Elisa Valencise Quaglio, Renata de Medeiros Dutra, Julio Pinheiro Baima, Silmeia Garcia Zanati Bazan and Ligia Yukie Sassaki |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ligia Yukie Sassaki, MD, PhD, Assistant Professor, Full Professor, Department of Internal Medicine, São Paulo State University (Unesp), Medical School, Botucatu, Av. Prof. Mário Rubens Guimarães Montenegro, s/n. Bairro: Rubião Junior, Botucatu, São Paulo, Brazil, Botucatu 18618686, São Paulo State, Brazil. ligia.sassaki@unesp.br |
| Key Words |
Tumor necrosis factor inhibitors; Inflammatory bowel disease; Heart failure; Adverse event; TNFα receptor |
| Core Tip |
Tumor necrosis factor inhibitors (anti-TNFs) are widely used for the treatment of inflammatory bowel diseases (IBD). However, heart failure, although rare, is an adverse event associated with the use of anti-TNFs in these patients. This review discusses the adverse events, especially heart failure, associated with the administration of anti-TNF therapy. We believe that our study makes a significant contribution to the literature because it discusses the current understanding in the field and proposes approaches to avoid the occurrence of adverse events due to anti-TNFs in patients with IBD. |
| Publish Date |
2023-05-19 07:45 |
| Citation |
Grillo TG, Silveira CFDSMP, Quaglio AEV, Dutra RM, Baima JP, Bazan SGZ, Sassaki LY. Acute heart failure as an adverse event of tumor necrosis factor inhibitor therapy in inflammatory bowel disease: A review of the literature. World J Cardiol 2023; 15(5): 217-228 |
| URL |
https://www.wjgnet.com/1949-8462/full/v15/i5/217.htm |
| DOI |
https://dx.doi.org/10.4330/wjc.v15.i5.217 |
